- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Metoclopramide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Metoclopramide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Nausea accounting for % of the Metoclopramide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Metoclopramide include Teva, Sanofi, Astellas, Adwya, and Biofarma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Metoclopramide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Nausea
Migraine
Gastroparesis
The key market players for global Metoclopramide market are listed below:
Teva
Sanofi
Astellas
Adwya
Biofarma
Apotex
Novartis
ASKA Seiyaku Asuka
Yang Sheng
Meda Pharma
Johnson and Johnson
GSK
Alkaloid Pharmaceuticals
Teuto Brasileiro
Mylan
EU-Pharma
Le Vet
Omega Laboratories
Orion Pharma
Pfizer
Wockhardt
Amneal Pharmaceuticals
Nidda
Ceva Sante Animale
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metoclopramide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metoclopramide, with price, sales, revenue and global market share of Metoclopramide from 2019 to 2022.
Chapter 3, the Metoclopramide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metoclopramide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Metoclopramide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metoclopramide.
Chapter 13, 14, and 15, to describe Metoclopramide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Metoclopramide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metoclopramide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Metoclopramide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Nausea
1.3.3 Migraine
1.3.4 Gastroparesis
1.4 Global Metoclopramide Market Size & Forecast
1.4.1 Global Metoclopramide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Metoclopramide Sales in Volume (2017-2028)
1.4.3 Global Metoclopramide Price (2017-2028)
1.5 Global Metoclopramide Production Capacity Analysis
1.5.1 Global Metoclopramide Total Production Capacity (2017-2028)
1.5.2 Global Metoclopramide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metoclopramide Market Drivers
1.6.2 Metoclopramide Market Restraints
1.6.3 Metoclopramide Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Metoclopramide Product and Services
2.1.4 Teva Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Metoclopramide Product and Services
2.2.4 Sanofi Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Astellas
2.3.1 Astellas Details
2.3.2 Astellas Major Business
2.3.3 Astellas Metoclopramide Product and Services
2.3.4 Astellas Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Adwya
2.4.1 Adwya Details
2.4.2 Adwya Major Business
2.4.3 Adwya Metoclopramide Product and Services
2.4.4 Adwya Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biofarma
2.5.1 Biofarma Details
2.5.2 Biofarma Major Business
2.5.3 Biofarma Metoclopramide Product and Services
2.5.4 Biofarma Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Metoclopramide Product and Services
2.6.4 Apotex Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Metoclopramide Product and Services
2.7.4 Novartis Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 ASKA Seiyaku Asuka
2.8.1 ASKA Seiyaku Asuka Details
2.8.2 ASKA Seiyaku Asuka Major Business
2.8.3 ASKA Seiyaku Asuka Metoclopramide Product and Services
2.8.4 ASKA Seiyaku Asuka Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Yang Sheng
2.9.1 Yang Sheng Details
2.9.2 Yang Sheng Major Business
2.9.3 Yang Sheng Metoclopramide Product and Services
2.9.4 Yang Sheng Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Meda Pharma
2.10.1 Meda Pharma Details
2.10.2 Meda Pharma Major Business
2.10.3 Meda Pharma Metoclopramide Product and Services
2.10.4 Meda Pharma Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Johnson and Johnson
2.11.1 Johnson and Johnson Details
2.11.2 Johnson and Johnson Major Business
2.11.3 Johnson and Johnson Metoclopramide Product and Services
2.11.4 Johnson and Johnson Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 GSK
2.12.1 GSK Details
2.12.2 GSK Major Business
2.12.3 GSK Metoclopramide Product and Services
2.12.4 GSK Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Alkaloid Pharmaceuticals
2.13.1 Alkaloid Pharmaceuticals Details
2.13.2 Alkaloid Pharmaceuticals Major Business
2.13.3 Alkaloid Pharmaceuticals Metoclopramide Product and Services
2.13.4 Alkaloid Pharmaceuticals Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Teuto Brasileiro
2.14.1 Teuto Brasileiro Details
2.14.2 Teuto Brasileiro Major Business
2.14.3 Teuto Brasileiro Metoclopramide Product and Services
2.14.4 Teuto Brasileiro Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Mylan
2.15.1 Mylan Details
2.15.2 Mylan Major Business
2.15.3 Mylan Metoclopramide Product and Services
2.15.4 Mylan Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 EU-Pharma
2.16.1 EU-Pharma Details
2.16.2 EU-Pharma Major Business
2.16.3 EU-Pharma Metoclopramide Product and Services
2.16.4 EU-Pharma Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Le Vet
2.17.1 Le Vet Details
2.17.2 Le Vet Major Business
2.17.3 Le Vet Metoclopramide Product and Services
2.17.4 Le Vet Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Omega Laboratories
2.18.1 Omega Laboratories Details
2.18.2 Omega Laboratories Major Business
2.18.3 Omega Laboratories Metoclopramide Product and Services
2.18.4 Omega Laboratories Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Orion Pharma
2.19.1 Orion Pharma Details
2.19.2 Orion Pharma Major Business
2.19.3 Orion Pharma Metoclopramide Product and Services
2.19.4 Orion Pharma Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Pfizer
2.20.1 Pfizer Details
2.20.2 Pfizer Major Business
2.20.3 Pfizer Metoclopramide Product and Services
2.20.4 Pfizer Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Wockhardt
2.21.1 Wockhardt Details
2.21.2 Wockhardt Major Business
2.21.3 Wockhardt Metoclopramide Product and Services
2.21.4 Wockhardt Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Amneal Pharmaceuticals
2.22.1 Amneal Pharmaceuticals Details
2.22.2 Amneal Pharmaceuticals Major Business
2.22.3 Amneal Pharmaceuticals Metoclopramide Product and Services
2.22.4 Amneal Pharmaceuticals Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Nidda
2.23.1 Nidda Details
2.23.2 Nidda Major Business
2.23.3 Nidda Metoclopramide Product and Services
2.23.4 Nidda Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Ceva Sante Animale
2.24.1 Ceva Sante Animale Details
2.24.2 Ceva Sante Animale Major Business
2.24.3 Ceva Sante Animale Metoclopramide Product and Services
2.24.4 Ceva Sante Animale Metoclopramide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Metoclopramide Breakdown Data by Manufacturer
3.1 Global Metoclopramide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Metoclopramide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Metoclopramide
3.4 Market Concentration Rate
3.4.1 Top 3 Metoclopramide Manufacturer Market Share in 2021
3.4.2 Top 6 Metoclopramide Manufacturer Market Share in 2021
3.5 Global Metoclopramide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Metoclopramide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metoclopramide Market Size by Region
4.1.1 Global Metoclopramide Sales in Volume by Region (2017-2028)
4.1.2 Global Metoclopramide Revenue by Region (2017-2028)
4.2 North America Metoclopramide Revenue (2017-2028)
4.3 Europe Metoclopramide Revenue (2017-2028)
4.4 Asia-Pacific Metoclopramide Revenue (2017-2028)
4.5 South America Metoclopramide Revenue (2017-2028)
4.6 Middle East and Africa Metoclopramide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Metoclopramide Sales in Volume by Type (2017-2028)
5.2 Global Metoclopramide Revenue by Type (2017-2028)
5.3 Global Metoclopramide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Metoclopramide Sales in Volume by Application (2017-2028)
6.2 Global Metoclopramide Revenue by Application (2017-2028)
6.3 Global Metoclopramide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Metoclopramide Sales by Type (2017-2028)
7.2 North America Metoclopramide Sales by Application (2017-2028)
7.3 North America Metoclopramide Market Size by Country
7.3.1 North America Metoclopramide Sales in Volume by Country (2017-2028)
7.3.2 North America Metoclopramide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Metoclopramide Sales by Type (2017-2028)
8.2 Europe Metoclopramide Sales by Application (2017-2028)
8.3 Europe Metoclopramide Market Size by Country
8.3.1 Europe Metoclopramide Sales in Volume by Country (2017-2028)
8.3.2 Europe Metoclopramide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Metoclopramide Sales by Type (2017-2028)
9.2 Asia-Pacific Metoclopramide Sales by Application (2017-2028)
9.3 Asia-Pacific Metoclopramide Market Size by Region
9.3.1 Asia-Pacific Metoclopramide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Metoclopramide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Metoclopramide Sales by Type (2017-2028)
10.2 South America Metoclopramide Sales by Application (2017-2028)
10.3 South America Metoclopramide Market Size by Country
10.3.1 South America Metoclopramide Sales in Volume by Country (2017-2028)
10.3.2 South America Metoclopramide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metoclopramide Sales by Type (2017-2028)
11.2 Middle East & Africa Metoclopramide Sales by Application (2017-2028)
11.3 Middle East & Africa Metoclopramide Market Size by Country
11.3.1 Middle East & Africa Metoclopramide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Metoclopramide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Metoclopramide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Metoclopramide
12.3 Metoclopramide Production Process
12.4 Metoclopramide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Metoclopramide Typical Distributors
13.3 Metoclopramide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Metoclopramide Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Metoclopramide Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Metoclopramide Product and Services
Table 6. Teva Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Metoclopramide Product and Services
Table 10. Sanofi Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Astellas Basic Information, Manufacturing Base and Competitors
Table 12. Astellas Major Business
Table 13. Astellas Metoclopramide Product and Services
Table 14. Astellas Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Adwya Basic Information, Manufacturing Base and Competitors
Table 16. Adwya Major Business
Table 17. Adwya Metoclopramide Product and Services
Table 18. Adwya Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biofarma Basic Information, Manufacturing Base and Competitors
Table 20. Biofarma Major Business
Table 21. Biofarma Metoclopramide Product and Services
Table 22. Biofarma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Apotex Basic Information, Manufacturing Base and Competitors
Table 24. Apotex Major Business
Table 25. Apotex Metoclopramide Product and Services
Table 26. Apotex Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Metoclopramide Product and Services
Table 30. Novartis Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. ASKA Seiyaku Asuka Basic Information, Manufacturing Base and Competitors
Table 32. ASKA Seiyaku Asuka Major Business
Table 33. ASKA Seiyaku Asuka Metoclopramide Product and Services
Table 34. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Yang Sheng Basic Information, Manufacturing Base and Competitors
Table 36. Yang Sheng Major Business
Table 37. Yang Sheng Metoclopramide Product and Services
Table 38. Yang Sheng Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Meda Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Meda Pharma Major Business
Table 41. Meda Pharma Metoclopramide Product and Services
Table 42. Meda Pharma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson and Johnson Major Business
Table 45. Johnson and Johnson Metoclopramide Product and Services
Table 46. Johnson and Johnson Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. GSK Basic Information, Manufacturing Base and Competitors
Table 48. GSK Major Business
Table 49. GSK Metoclopramide Product and Services
Table 50. GSK Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Alkaloid Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Alkaloid Pharmaceuticals Major Business
Table 53. Alkaloid Pharmaceuticals Metoclopramide Product and Services
Table 54. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Teuto Brasileiro Basic Information, Manufacturing Base and Competitors
Table 56. Teuto Brasileiro Major Business
Table 57. Teuto Brasileiro Metoclopramide Product and Services
Table 58. Teuto Brasileiro Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Mylan Basic Information, Manufacturing Base and Competitors
Table 60. Mylan Major Business
Table 61. Mylan Metoclopramide Product and Services
Table 62. Mylan Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. EU-Pharma Basic Information, Manufacturing Base and Competitors
Table 64. EU-Pharma Major Business
Table 65. EU-Pharma Metoclopramide Product and Services
Table 66. EU-Pharma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Le Vet Basic Information, Manufacturing Base and Competitors
Table 68. Le Vet Major Business
Table 69. Le Vet Metoclopramide Product and Services
Table 70. Le Vet Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Omega Laboratories Basic Information, Manufacturing Base and Competitors
Table 72. Omega Laboratories Major Business
Table 73. Omega Laboratories Metoclopramide Product and Services
Table 74. Omega Laboratories Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Orion Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Orion Pharma Major Business
Table 77. Orion Pharma Metoclopramide Product and Services
Table 78. Orion Pharma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Metoclopramide Product and Services
Table 82. Pfizer Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 84. Wockhardt Major Business
Table 85. Wockhardt Metoclopramide Product and Services
Table 86. Wockhardt Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 88. Amneal Pharmaceuticals Major Business
Table 89. Amneal Pharmaceuticals Metoclopramide Product and Services
Table 90. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Nidda Basic Information, Manufacturing Base and Competitors
Table 92. Nidda Major Business
Table 93. Nidda Metoclopramide Product and Services
Table 94. Nidda Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Ceva Sante Animale Basic Information, Manufacturing Base and Competitors
Table 96. Ceva Sante Animale Major Business
Table 97. Ceva Sante Animale Metoclopramide Product and Services
Table 98. Ceva Sante Animale Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Global Metoclopramide Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 100. Global Metoclopramide Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 101. Market Position of Manufacturers in Metoclopramide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 102. Global Metoclopramide Production Capacity by Company, (K Units): 2020 VS 2021
Table 103. Head Office and Metoclopramide Production Site of Key Manufacturer
Table 104. Metoclopramide New Entrant and Capacity Expansion Plans
Table 105. Metoclopramide Mergers & Acquisitions in the Past Five Years
Table 106. Global Metoclopramide Sales by Region (2017-2022) & (K Units)
Table 107. Global Metoclopramide Sales by Region (2023-2028) & (K Units)
Table 108. Global Metoclopramide Revenue by Region (2017-2022) & (USD Million)
Table 109. Global Metoclopramide Revenue by Region (2023-2028) & (USD Million)
Table 110. Global Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 111. Global Metoclopramide Sales by Type (2023-2028) & (K Units)
Table 112. Global Metoclopramide Revenue by Type (2017-2022) & (USD Million)
Table 113. Global Metoclopramide Revenue by Type (2023-2028) & (USD Million)
Table 114. Global Metoclopramide Price by Type (2017-2022) & (US$/Unit)
Table 115. Global Metoclopramide Price by Type (2023-2028) & (US$/Unit)
Table 116. Global Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 117. Global Metoclopramide Sales by Application (2023-2028) & (K Units)
Table 118. Global Metoclopramide Revenue by Application (2017-2022) & (USD Million)
Table 119. Global Metoclopramide Revenue by Application (2023-2028) & (USD Million)
Table 120. Global Metoclopramide Price by Application (2017-2022) & (US$/Unit)
Table 121. Global Metoclopramide Price by Application (2023-2028) & (US$/Unit)
Table 122. North America Metoclopramide Sales by Country (2017-2022) & (K Units)
Table 123. North America Metoclopramide Sales by Country (2023-2028) & (K Units)
Table 124. North America Metoclopramide Revenue by Country (2017-2022) & (USD Million)
Table 125. North America Metoclopramide Revenue by Country (2023-2028) & (USD Million)
Table 126. North America Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 127. North America Metoclopramide Sales by Type (2023-2028) & (K Units)
Table 128. North America Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 129. North America Metoclopramide Sales by Application (2023-2028) & (K Units)
Table 130. Europe Metoclopramide Sales by Country (2017-2022) & (K Units)
Table 131. Europe Metoclopramide Sales by Country (2023-2028) & (K Units)
Table 132. Europe Metoclopramide Revenue by Country (2017-2022) & (USD Million)
Table 133. Europe Metoclopramide Revenue by Country (2023-2028) & (USD Million)
Table 134. Europe Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 135. Europe Metoclopramide Sales by Type (2023-2028) & (K Units)
Table 136. Europe Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 137. Europe Metoclopramide Sales by Application (2023-2028) & (K Units)
Table 138. Asia-Pacific Metoclopramide Sales by Region (2017-2022) & (K Units)
Table 139. Asia-Pacific Metoclopramide Sales by Region (2023-2028) & (K Units)
Table 140. Asia-Pacific Metoclopramide Revenue by Region (2017-2022) & (USD Million)
Table 141. Asia-Pacific Metoclopramide Revenue by Region (2023-2028) & (USD Million)
Table 142. Asia-Pacific Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 143. Asia-Pacific Metoclopramide Sales by Type (2023-2028) & (K Units)
Table 144. Asia-Pacific Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 145. Asia-Pacific Metoclopramide Sales by Application (2023-2028) & (K Units)
Table 146. South America Metoclopramide Sales by Country (2017-2022) & (K Units)
Table 147. South America Metoclopramide Sales by Country (2023-2028) & (K Units)
Table 148. South America Metoclopramide Revenue by Country (2017-2022) & (USD Million)
Table 149. South America Metoclopramide Revenue by Country (2023-2028) & (USD Million)
Table 150. South America Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 151. South America Metoclopramide Sales by Type (2023-2028) & (K Units)
Table 152. South America Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 153. South America Metoclopramide Sales by Application (2023-2028) & (K Units)
Table 154. Middle East & Africa Metoclopramide Sales by Region (2017-2022) & (K Units)
Table 155. Middle East & Africa Metoclopramide Sales by Region (2023-2028) & (K Units)
Table 156. Middle East & Africa Metoclopramide Revenue by Region (2017-2022) & (USD Million)
Table 157. Middle East & Africa Metoclopramide Revenue by Region (2023-2028) & (USD Million)
Table 158. Middle East & Africa Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 159. Middle East & Africa Metoclopramide Sales by Type (2023-2028) & (K Units)
Table 160. Middle East & Africa Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 161. Middle East & Africa Metoclopramide Sales by Application (2023-2028) & (K Units)
Table 162. Metoclopramide Raw Material
Table 163. Key Manufacturers of Metoclopramide Raw Materials
Table 164. Direct Channel Pros & Cons
Table 165. Indirect Channel Pros & Cons
Table 166. Metoclopramide Typical Distributors
Table 167. Metoclopramide Typical Customers
List of Figures
Figure 1. Metoclopramide Picture
Figure 2. Global Metoclopramide Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Metoclopramide Revenue Market Share by Application in 2021
Figure 6. Nausea
Figure 7. Migraine
Figure 8. Gastroparesis
Figure 9. Global Metoclopramide Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Metoclopramide Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Metoclopramide Sales (2017-2028) & (K Units)
Figure 12. Global Metoclopramide Price (2017-2028) & (US$/Unit)
Figure 13. Global Metoclopramide Production Capacity (2017-2028) & (K Units)
Figure 14. Global Metoclopramide Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Metoclopramide Market Drivers
Figure 16. Metoclopramide Market Restraints
Figure 17. Metoclopramide Market Trends
Figure 18. Global Metoclopramide Sales Market Share by Manufacturer in 2021
Figure 19. Global Metoclopramide Revenue Market Share by Manufacturer in 2021
Figure 20. Metoclopramide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Metoclopramide Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Metoclopramide Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Metoclopramide Sales Market Share by Region (2017-2028)
Figure 24. Global Metoclopramide Revenue Market Share by Region (2017-2028)
Figure 25. North America Metoclopramide Revenue (2017-2028) & (USD Million)
Figure 26. Europe Metoclopramide Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Metoclopramide Revenue (2017-2028) & (USD Million)
Figure 28. South America Metoclopramide Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Metoclopramide Revenue (2017-2028) & (USD Million)
Figure 30. Global Metoclopramide Sales Market Share by Type (2017-2028)
Figure 31. Global Metoclopramide Revenue Market Share by Type (2017-2028)
Figure 32. Global Metoclopramide Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Metoclopramide Sales Market Share by Application (2017-2028)
Figure 34. Global Metoclopramide Revenue Market Share by Application (2017-2028)
Figure 35. Global Metoclopramide Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Metoclopramide Sales Market Share by Type (2017-2028)
Figure 37. North America Metoclopramide Sales Market Share by Application (2017-2028)
Figure 38. North America Metoclopramide Sales Market Share by Country (2017-2028)
Figure 39. North America Metoclopramide Revenue Market Share by Country (2017-2028)
Figure 40. United States Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Metoclopramide Sales Market Share by Type (2017-2028)
Figure 44. Europe Metoclopramide Sales Market Share by Application (2017-2028)
Figure 45. Europe Metoclopramide Sales Market Share by Country (2017-2028)
Figure 46. Europe Metoclopramide Revenue Market Share by Country (2017-2028)
Figure 47. Germany Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Metoclopramide Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Metoclopramide Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Metoclopramide Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Metoclopramide Revenue Market Share by Region (2017-2028)
Figure 56. China Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Metoclopramide Sales Market Share by Type (2017-2028)
Figure 63. South America Metoclopramide Sales Market Share by Application (2017-2028)
Figure 64. South America Metoclopramide Sales Market Share by Country (2017-2028)
Figure 65. South America Metoclopramide Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Metoclopramide Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Metoclopramide Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Metoclopramide Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Metoclopramide Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Metoclopramide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Metoclopramide in 2021
Figure 77. Manufacturing Process Analysis of Metoclopramide
Figure 78. Metoclopramide Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
